| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.15M | - | |
| Dir | 4.52M | $14.38M | - | |
| CEO | 2.26M | $7.19M | - | |
| Dir | 1.24M | $3.95M | - | |
| Other | 1.11M | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $8.82 | $100,941.94 | -0.2% | -14.9% | -39.7% | |
| Mar 28, 2024 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 65,000 | $10.10 | $656,500.00 | -5.9% | -12.1% | -41.7% | |
| Mar 21, 2024 | Marriott Tina73 | President And COO | Sale+OE | 8,000 | $10.75 | $85,979.89 | -0.6% | -14.1% | -37.3% | |
| Mar 19, 2024 | Borgeson Blake69 | Director | Sell | 20,054 | $10.79 | $216,422.77 | -0.3% | -12.8% | -38.8% | |
| Mar 13, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 50,000 | $10.74 | $537,190.00 | -2.0% | -21.9% | -45.9% | |
| Mar 6, 2024 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 61,319 | $11.73 | $719,504.90 | -5.2% | -25.7% | -44.9% | |
| Mar 5, 2024 | Borgeson Blake69 | Director | Sell | 20,054 | $12.06 | $241,805.12 | -0.3% | -27.9% | -44.8% | |
| Feb 22, 2024 | Marriott Tina73 | President And COO | Sale+OE | 8,000 | $14.90 | $119,160.00 | -1.2% | -37.6% | -38.1% | |
| Feb 20, 2024 | Borgeson Blake69 | Director | Sell | 20,054 | $12.32 | $247,124.87 | -0.1% | -22.3% | -13.7% | |
| Feb 14, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 50,000 | $10.16 | $507,984.99 | -1.4% | -8.0% | -22.2% |